BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 16038794)

  • 1. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
    Wain CM; Westwick J; Ward SG
    Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways.
    Chernock RD; Cherla RP; Ganju RK
    Blood; 2001 Feb; 97(3):608-15. PubMed ID: 11157475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells.
    Aman MJ; Lamkin TD; Okada H; Kurosaki T; Ravichandran KS
    J Biol Chem; 1998 Dec; 273(51):33922-8. PubMed ID: 9852043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells.
    Brauweiler A; Tamir I; Marschner S; Helgason CD; Cambier JC
    J Immunol; 2001 Jul; 167(1):204-11. PubMed ID: 11418650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dynamics of protein kinase B regulation during B cell antigen receptor engagement.
    Astoul E; Watton S; Cantrell D
    J Cell Biol; 1999 Jun; 145(7):1511-20. PubMed ID: 10385529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the inositol phosphatase SHIP in B cell receptor-induced Ca2+ oscillatory response.
    Okada H; Bolland S; Hashimoto A; Kurosaki M; Kabuyama Y; Iino M; Ravetch JV; Kurosaki T
    J Immunol; 1998 Nov; 161(10):5129-32. PubMed ID: 9820480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes.
    Sotsios Y; Whittaker GC; Westwick J; Ward SG
    J Immunol; 1999 Dec; 163(11):5954-63. PubMed ID: 10570282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
    Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
    Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct waves of membrane-proximal B cell antigen receptor signaling differentially regulated by Src homology 2-containing inositol polyphosphate 5-phosphatase.
    Krahn AK; Ma K; Hou S; Duronio V; Marshall AJ
    J Immunol; 2004 Jan; 172(1):331-9. PubMed ID: 14688341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
    Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
    J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity.
    Ma K; Cheung SM; Marshall AJ; Duronio V
    Cell Signal; 2008 Apr; 20(4):684-94. PubMed ID: 18249092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SH2 domain-containing inositol 5'-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcgammaRIIb1-mediated inhibition of B cell receptor signaling.
    Gupta N; Scharenberg AM; Fruman DA; Cantley LC; Kinet JP; Long EO
    J Biol Chem; 1999 Mar; 274(11):7489-94. PubMed ID: 10066815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP.
    Fang H; Pengal RA; Cao X; Ganesan LP; Wewers MD; Marsh CB; Tridandapani S
    J Immunol; 2004 Jul; 173(1):360-6. PubMed ID: 15210794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
    Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
    Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
    Sármay G; Koncz G; Pecht I; Gergely J
    Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual role of H-Ras in regulation of lymphocyte function antigen-1 activity by stromal cell-derived factor-1alpha: implications for leukocyte transmigration.
    Weber KS; Ostermann G; Zernecke A; Schröder A; Klickstein LB; Weber C
    Mol Biol Cell; 2001 Oct; 12(10):3074-86. PubMed ID: 11598192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling.
    Liu Q; Oliveira-Dos-Santos AJ; Mariathasan S; Bouchard D; Jones J; Sarao R; Kozieradzki I; Ohashi PS; Penninger JM; Dumont DJ
    J Exp Med; 1998 Oct; 188(7):1333-42. PubMed ID: 9763612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motility.
    Harris SJ; Parry RV; Foster JG; Blunt MD; Wang A; Marelli-Berg F; Westwick J; Ward SG
    J Immunol; 2011 Apr; 186(8):4936-45. PubMed ID: 21402888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.